Market Outlook - The market for inorganic iodides is expected to grow significantly due to increasing medical expenditures driven by rising living standards, aging populations, and heightened health awareness [2][3] - The demand for contrast agents in the diagnosis of diseases such as tumors, cardiovascular diseases, and neurological disorders is projected to steadily increase, expanding the domestic contrast agent market [2][3] - The rapid development of the global pharmaceutical industry, particularly in new drug research and development, is expected to further drive the demand for high-quality pharmaceutical intermediates [3] Production Capacity Expansion - The company is establishing a new production project for 4,000 tons/year of inorganic iodides to enhance capacity and diversify its product offerings, focusing on high-value products for pharmaceutical and electronic applications [4] Competitive Advantages - **Resource Recycling and Service Integration**: The company has developed a unique "iodine resource recycling" industry chain, reducing reliance on imported iodine and lowering procurement costs while providing integrated solutions to clients [4] - **Regulatory Compliance and Scale**: As a leading iodine resource utilization enterprise, the company has a robust capacity for iodine recycling and complies with environmental regulations, enhancing collaboration with clients [4][5] - **Technological Innovation**: The company emphasizes continuous technological advancement and has established a comprehensive R&D and talent incentive system, leading to industry-leading processes and patented technologies [5] - **Quality Control and Client Relationships**: A thorough quality control system ensures product quality, with core products certified by authoritative bodies, fostering long-term trust with major clients [5] Shareholder Information - The company plans to release 19,630,000 shares from lock-up on December 11, 2025, with no current plans for shareholder reductions communicated [5]

Investment Rating - The report maintains an "Overweight" rating for the basic chemical industry [1][9]. Core Viewpoints - The basic chemical index outperformed the CSI 300 index by 2.93 percentage points, with a weekly increase of 2.50% compared to a decrease of 0.43% for the CSI 300 [3][15]. - Key sub-industries showing significant gains include potassium fertilizer (10.66%), fluorochemicals (7.24%), phosphorus fertilizer and phosphorus chemicals (6.60%), organic silicon (5.85%), and non-metallic materials III (3.75%) [16][19]. - The report highlights a positive trend in the vitamin market, with prices for Vitamin A and E increasing due to proactive price hikes by major producers, leading to heightened market activity [6][9]. Summary by Sections Market Trends - The basic chemical index increased by 2.50% over the past week, outperforming the CSI 300 index [15]. - The top-performing sub-industries included potassium fertilizer, fluorochemicals, and phosphorus chemicals [16]. Chemical Product Price Trends - The top five products with the highest weekly price increases were hydrochloric acid (Shandong) at 57.14%, NYMEX natural gas at 24.85%, concentrated nitric acid at 9.68%, and domestic vitamins E and A at 8.70% and 6.67% respectively [24][28]. - The products with the largest weekly price declines included POM (injection) at -14.06%, international butadiene at -11.64%, and coal tar at -7.29% [24][25]. Investment Recommendations - The report suggests focusing on several key sectors: refrigerants, chemical fibers, tire manufacturing, and agricultural chemicals, with specific companies highlighted for potential investment [9][45]. - Notable companies to watch include Jinshi Resources, Juhua Co., and Wanhu Chemical among others [9][45].

Group 1 - The core viewpoint of the article highlights that Boyuan Co., Ltd. (SZ 301617) is actively engaging with investors, indicating a focus on transparency and communication regarding its business operations [1] - Boyuan Co., Ltd. reported that its revenue composition for the year 2024 is entirely from the chemical industry, with a 100.0% share [2] - As of the latest update, Boyuan Co., Ltd. has a market capitalization of 12.3 billion yuan [2]

Group 1: Company Overview - The company, Shandong Boyuan Pharmaceutical Chemical Co., Ltd., has a stock code of 301617 and is referred to as Boyuan Co. [1] Group 2: Investor Relations Activity - The investor relations activity involved a specific audience survey and included participants from various financial institutions such as Nuode Fund, Changjiang Securities, and others [2] - The meeting took place on October 31, 2025, in the Boyuan Co. conference room [2] Group 3: Product Capacity and Applications - The company has an existing production capacity of 4,100 tons/year for iodide products, which include inorganic iodides like potassium iodide and sodium iodide, as well as organic iodides such as trimethyl iodide [2][3] - Iodine and its derivatives are crucial raw materials in medical, agricultural, industrial, and nutritional fields, with applications in X-ray contrast agents, disinfectants, and LCD/LED screen polarizers [3] Group 4: Strategic Partnerships - Boyuan Co. signed a strategic cooperation framework agreement with Dongsheng Technology in October 2025, focusing on resource integration and technological innovation to enhance competitiveness in the solid-state battery materials industry [2] Group 5: Global Iodine Market Insights - According to SQM's 2024 annual report, the downstream application structure of iodine shows that X-ray contrast agents, pharmaceutical manufacturing, and LCD panel manufacturing account for approximately 63% of global consumption [3] - The global iodine production is concentrated in Chile, Japan, and the USA, which together account for 88% of total sales, with Chilean companies alone contributing 60% of global iodine sales [3]

Group 1: Iodine and Its Applications - Iodine and its derivatives are crucial raw materials in medical, agricultural, industrial, and nutritional fields, widely used in various product formulations as key components or catalysts [2] - The downstream application structure of iodine includes three core areas: X-ray contrast agents, pharmaceutical manufacturing, and LCD panel manufacturing, which together account for approximately 63% of global consumption [2] - Major iodine production is concentrated in Chile, Japan, and the United States, with these three countries accounting for 88% of global sales [2][3] Group 2: Company Product Overview - The company’s inorganic iodide products include potassium iodide, potassium iodate, sodium iodide, hydriodic acid, and cuprous iodide, primarily used in pharmaceuticals, pesticides, feed, and optoelectronic materials [3] - Organic iodide products include trimethylsilyl iodide and methyl iodide, with trimethylsilyl iodide being used as a protecting group in organic synthesis, particularly in the production of antibiotics [3] Group 3: Strategic Developments - The company signed a strategic cooperation framework agreement with a technology partner in October 2025 to enhance the industrialization of sulfide solid electrolyte technology through resource integration and innovation [3] - The company’s 4000 tons/year inorganic iodide production project is expected to be completed by the end of 2025, with a production capacity of 300 tons of lithium iodide upon full operation [3]

Market Overview - The chemical products sector experienced a decline of 0.57% on the trading day, with Boyuan Co., Ltd. leading the losses [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Stock Performance - Notable gainers in the chemical products sector included: - Hangzhou Oxygen Plant Co., Ltd. (002430) with a closing price of 29.52, up 9.99% and a trading volume of 494,700 shares, totaling 1.43 billion yuan [1] - Pioneer New Materials (300163) closed at 4.93, up 6.94% with a trading volume of 1,542,200 shares, totaling 759 million yuan [1] - Jinrongzi (002407) closed at 26.50, up 6.26% with a trading volume of 2,445,100 shares, totaling 6.408 billion yuan [1] - Major decliners included: - Boyuan Co., Ltd. (301617) closed at 94.00, down 7.66% with a trading volume of 78,600 shares, totaling 763 million yuan [2] - Jinhua New Materials (920015) closed at 58.33, down 7.29% with a trading volume of 132,100 shares, totaling 810 million yuan [2] - Poly United (002037) closed at 10.10, down 6.13% with a trading volume of 247,400 shares, totaling 254 million yuan [2] Capital Flow - The chemical products sector saw a net outflow of 933 million yuan from institutional investors, while retail investors contributed a net inflow of 665 million yuan [2] - The capital flow for specific stocks indicated: - Hangzhou Oxygen Plant Co., Ltd. had a net inflow of 1.52 billion yuan from institutional investors, while retail investors had a net outflow of 948.96 million yuan [3] - Yongtai Technology (002326) experienced a net inflow of 1.25 billion yuan from institutional investors, with a net outflow of 2.22 billion yuan from retail investors [3] - Yahua Group (002497) had a net inflow of 1.08 billion yuan from institutional investors, while retail investors saw a net outflow of 657.87 million yuan [3]

Market Overview - The chemical products sector increased by 1.38% on October 29, with JinHua New Materials leading the gains [1] - The Shanghai Composite Index closed at 4016.33, up 0.7%, while the Shenzhen Component Index closed at 13691.38, up 1.95% [1] Top Performers - JinHua New Materials (Code: 920015) closed at 62.92, up 30.00% with a trading volume of 135,600 shares and a turnover of 746 million [1] - WeiLan Bio (Code: 603739) closed at 15.51, up 10.00% with a trading volume of 96,900 shares and a turnover of 148 million [1] - YiNuoWei (Code: 920261) closed at 16.34, up 7.08% with a trading volume of 48,000 shares and a turnover of 75.93 million [1] Underperformers - XianFeng New Materials (Code: 300163) closed at 4.61, down 7.62% with a trading volume of 1,672,400 shares and a turnover of 787 million [2] - JinJi Co., Ltd. (Code: 300798) closed at 7.63, down 5.92% with a trading volume of 230,600 shares and a turnover of 178 million [2] - KaiLi New Materials (Code: 6888889) closed at 41.10, down 5.30% with a trading volume of 40,900 shares and a turnover of 170 million [2] Capital Flow - The chemical products sector experienced a net outflow of 84.36 million from institutional investors, while retail investors saw a net inflow of 87.49 million [2][3] - Major stocks like KaiMeiTeQi (Code: 002549) had a net inflow of 200 million from institutional investors, while DeMeiHuaGong (Code: 002054) saw a net outflow of 155 million [3]

Core Viewpoint - The stock of Shandong Boyuan Pharmaceutical Chemical Co., Ltd. has experienced significant fluctuations, with a year-to-date increase of 151.82% but a recent decline of 3.42% over the last five trading days [1] Group 1: Company Overview - Shandong Boyuan Pharmaceutical Chemical Co., Ltd. was established on August 6, 2008, and is located in Shouguang City, Shandong Province [2] - The company specializes in the research, production, and sales of fine chemicals, including organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane [2] - The main revenue composition includes iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [2] Group 2: Financial Performance - For the period from January to September 2025, Boyuan achieved operating revenue of 1.073 billion yuan, representing a year-on-year growth of 6.60% [2] - The net profit attributable to the parent company was 132 million yuan, showing a year-on-year decrease of 22.53% [2] - Cumulative cash dividends since the A-share listing amount to 88.408 million yuan [3] Group 3: Shareholder and Market Activity - As of October 20, 2025, the number of shareholders increased by 25.58% to 13,300, with an average of 2,502 circulating shares per person, a decrease of 20.37% [2] - The stock has appeared on the "Dragon and Tiger List" six times this year, with the most recent appearance on October 17, where it recorded a net buy of -20.2738 million yuan [1] - Major shareholders include various new institutional investors, with significant holdings from funds such as Zhonghang New Start Flexible Allocation Mixed A and Hong Kong Central Clearing Limited [3]

Core Insights - On October 24, Boyuan Co., Ltd. saw a stock price increase of 14.34% with a trading volume of 902 million yuan [1] - The company experienced a net financing outflow of 982.88 million yuan on the same day, with a total financing and securities balance of 1.92 billion yuan [1][2] Financing and Trading Data - On October 24, Boyuan Co., Ltd. had a financing purchase of 8970.56 million yuan, with a current financing balance of 1.92 billion yuan, representing 5.58% of the circulating market value [2] - There were no short sales or repayments on the same day, with a short balance of 0.00 yuan [2] Company Overview - Boyuan Co., Ltd. is located in Shouguang City, Shandong Province, and was established on August 6, 2008, with a listing date of December 11, 2024 [2] - The company specializes in the research, production, and sales of fine chemicals, including organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane [2] - The main revenue composition includes iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [2] Shareholder and Financial Performance - As of October 20, the number of shareholders for Boyuan Co., Ltd. was 13,300, an increase of 25.58% from the previous period, with an average of 2502 circulating shares per person, a decrease of 20.37% [3] - For the period from January to September 2025, the company reported a revenue of 1.073 billion yuan, a year-on-year increase of 6.60%, while the net profit attributable to shareholders decreased by 22.53% to 132 million yuan [3] Dividend and Institutional Holdings - Boyuan Co., Ltd. has distributed a total of 88.408 million yuan in dividends since its A-share listing [4] - As of September 30, 2025, several new institutional shareholders have emerged among the top ten circulating shareholders, including Zhonghang New Start Flexible Allocation Mixed A and Hong Kong Central Clearing Limited [4]

Core Insights - The chemical products sector experienced a slight increase of 0.11% on October 24, with Boyuan Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3950.31, up 0.71%, while the Shenzhen Component Index closed at 13289.18, up 2.02% [1] Sector Performance - Boyuan Co., Ltd. (301617) closed at 102.79, with a significant increase of 14.34% and a trading volume of 91,000 shares, resulting in a transaction value of 902 million yuan [1] - Yahua Group (002497) saw a rise of 10.03%, closing at 17.88 with a trading volume of 1.2768 million shares [1] - Licheng Industrial (001218) increased by 6.97%, closing at 23.78 with a trading volume of 95,700 shares [1] - Guangdong Hongda (002683) rose by 4.77%, closing at 39.94 with a trading volume of 237,200 shares [1] - Other notable performers include Shengda Biological (603079) up 4.29%, Jianlong Micro-Nano (688357) up 4.04%, and Gaodian New Materials (300200) up 3.86% [1] Capital Flow - The chemical products sector saw a net outflow of 291 million yuan from main funds, while retail investors contributed a net inflow of 379 million yuan [1]